CareTrust REIT (CTRE) just paired a raised 2026 earnings outlook with a large U.K. care home acquisition program, giving investors fresh information on both portfolio growth plans and expected profitability.
CareTrust REIT’s latest guidance hike and U.K. expansion come after a mixed stretch for the shares, with the 30 day share price return down 6.7% and the 1 year total shareholder return at 14.0%, while the 5 year total shareholder return of 115.6% points to longer term momentum that has been strong.
Scan other healthcare-focused real estate ideas that are moving on similar themes of international expansion and earnings guidance shifts with our curated list of list of solid balance sheet and fundamentals (25 results)
CareTrust REIT now trades at a clear gap to both analyst targets and intrinsic value estimates. With the stock hesitating after the U.K. deal, the question is where a fair entry really lines up inside that spread.
Against a last close of $36.03, the most followed narrative pegs CareTrust REIT’s fair value at $45.15, framing the U.K. build out and earnings guidance through a discounted cash flow lens using a 7.28% discount rate.
The multi engine growth model across U.S. skilled nursing, U.K. care homes and SHOP is now backed by roughly US$1.5b of investments year to date in 2026 and about US$1.9b deployed in 2026 overall. This points to a larger income producing base that can feed future revenue and earnings.
See why 61 investors see CareTrust REIT as 20% undervalued.
Result: Fair Value of $45.15 (UNDERVALUED)
Still, the CareTrust REIT narrative leans heavily on ongoing deal flow and healthy rent coverage, so weaker acquisition yields or operator strain could quickly test that fair value gap.
Find out about the key risks to this CareTrust REIT narrative.
If the CareTrust REIT setup sounds compelling on paper, move quickly to stress test the numbers yourself and decide where you land. To see what optimistic investors are focusing on, review the 5 key rewards.
If CareTrust REIT has you rethinking your watchlist, do not stop at a single ticker. Use focused screeners to surface other opportunities that match your risk and income preferences.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com